DENVER--(BUSINESS WIRE)--Colorado’s state legislature today declared February to be “Fibroid Awareness Month,” a designation meant to call attention to uterine fibroids, an extremely common condition that is the cause of significant health problems for premenopausal women.
The legislature’s awareness of the challenges associated with uterine fibroids resulted from the efforts of Michael L. Moore, M.D. an OB/GYN and principal of the Advanced Women’s Health Institute in Denver, a medical group that advocates for less-invasive treatment solutions for women.
“Because they are so common, a much better awareness of the issues associated with uterine fibroids is of vital importance to all women and their families,” Dr. Moore said. “While they are typically benign, uterine fibroids can cause a variety of serious health problems including the need for a hysterectomy. Our goal at Advanced Women’s Health Institute is to help bring attention to the health risks that can result from fibroids and to provide minimally and non-invasive treatment options for women. I’d like to thank the Colorado legislature for taking this important step to increase our state’s awareness of this condition and the new and innovative options available for treatment.”
Dr. Moore is currently serving as a principal investigator in the SONATA Trial (Gynesonics, Redwood City, CA), evaluating an incision-free, and uterus preserving investigative procedure for fibroids.
According to medical literature, in the United States about 70-80 percent of women will develop uterine fibroids by age 50. In addition, approximately 200,000 hysterectomies are performed in the United States each year because of symptomatic fibroids, according to the New England Journal of Medicine.